Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trialMartina Schneider, Nina Wressnigg, Annegret Bitzer et al.|The Lancet|2023Cited by 218
Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trialNina Wressnigg, Wolfgang Bender, Romana Hochreiter et al.|The Lancet Infectious Diseases|2020Cited by 104